₹ 953.75
-20.25 (-2.08%)
J
Jenburkt Pharmaceuticals
₹ 953.75
Jenburkt Pharmaceuticals EPS Summary
The latest quarterly EPS of Jenburkt Pharmaceuticals as of Q2 Sep 2026 stands at ₹23.13. This is a 73.39% growth quarter on quarter and 0.43% growth same quarter last year. For the FY2026 the EPS of Jenburkt Pharmaceuticals stands at ₹78.71. This is a 8.34% growth compared with FY2025.
Jenburkt Pharmaceuticals EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

